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We have previously shown that the 3-hydroxy-3-methylgl-
utaryl coenzyme A reductase inhibitor (HMGCRI) atorv-
astatin is therapeutic in experimental autoimmune
encephalomyelitis (EAE) while also inducing a sustained
phosphorylation of the MAPK Erk1 that is important for
inducing T cell anergy. However it is also known, that
HMGCRI also influence the antigen presenting cell com-
partment including dendritic cells (DC). This led us to
investigate the role of Erk1 in DC biology in more detail.
Indeed bone-marrow derived dendritic cells from Erk1
deficient mice had an increased migratory capacity when
compared with DC isolated from wildtype littermate
mice. As a likely consequence to cytoskeletal regulation,
Erk1-/- DC had an increased surface expression of costim-
ulatory molecules and were more potent to prime T cells
in vivo. To investigate the implications of these findings in
an inflammatory scenario, we induced EAE (experimental
autoimmune encephalomyelitis) in Erk1-/- and Erk1+/+
mice with myelin oligodendrocyte glycoprotein peptide
35–55 (MOG35–55) and could show that a deficiency of
this MAPK results in a moderate increase in disease sever-
ity. To differentiate the role of Erk1 between peripheral
immune system and the brain compartment we induced
EAE in Erk1+/+ mice harboring Erk1-/- immune cells by
applying bone marrow chimeras (Erk1-/- --> Erk1+/+). We
report that Erk1 has an important regulatory function in
the immune system as shown by pronounced disease
severity in Erk1-/- --> Erk1+/+ bone marrow chimeras. All
together these results indicate the significance of Erk1 in
regulating DC functions that are relevant for T cell prim-
ing and neuroinflammation, and thus signal the impor-
tance of therapeutically targeting this MAPK for the
treatment of autoimmune diseases.
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